Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Brain Behav Immun. 2021 Mar 9:S0889-1591(21)00106-9. doi: 10.1016/j.bbi.2021.03.004

Table 2.

Descriptive Statistics for Depressive symptoms, CRP and Stress Measures

Variable N % α Mean (SD)
Criterion:
Depressive Symptoms (CES-D)
 Pre-treatment 187 .908 12.95 (10.25)
 Post-treatment 144 .917 10.70 (9.91)
 6 Month Follow-up 178 .924 12.06 (10.80)
 12 Month Follow-up 176 .911 11.52 (9.76)
 18 Month Follow-up 172 .916 11.14 (10.00)
Clinically Significant Depressive Symptoms (CES-D ≥ 16)
 Pre-treatment 63 33.69 %
 Post-treatment 38 26.39 %
 6 Month Follow-up 54 30.34 %
 12 Month Follow-up 44 25.00 %
 18 Month Follow-up 45 26.16 %
Clinically Significant Depressive Symptoms (CES-D ≥ 20)
 Pre-treatment 42 22.46 %
 Post-treatment 26 18.06 %
 6 Month Follow-up 38 21.35 %
 12 Month Follow-up 34 19.32 %
 18 Month Follow-up 29 16.86 %
Predictor:
CRP (mg/L)
 Pre-treatment 185 3.44 (5.25)
 Post-treatment 144 3.74 (7.85)
 6 Month Follow-up 168 2.41 (3.76)
 12 Month Follow-up 159 2.30 (3.60)
 18 Month Follow-up 159 2.56 (4.45)
Stress Moderators:
Cancer-related Intrusive Thoughts (IES)
 Pre-treatment 187 .898 1.78 (1.35)
 Post-treatment 144 .909 1.12 (1.18)
 6 Month Follow-up 177 .903 1.21 (1.18)
 12 Month Follow-up 176 .884 1.15 (1.11)
 18 Month Follow-up 172 .892 1.08 (1.09)
General stress perceptions (PSS)
 Pre-treatment 187 .876 15.50 (6.63)
 Post-treatment 144 .909 13.16 (6.98)
 6 Month Follow-up 178 .925 14.87 (7.68)
 12 Month Follow-up 176 .912 14.52 (7.04)
 18 Month Follow-up 172 .907 14.46 (7.25)
Childhood stress (CTQ) 184 .928 37.24 (14.13)

CES-D = Center for Epidemiological Studies – Depression; CRP = C-reactive Protein; IES = Impact of Event Scale; PSS = Perceived Stress Scale; CTQ = Childhood Trauma Questionnaire.